Compare DIOD & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIOD | HAE |
|---|---|---|
| Founded | 1959 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.6B |
| IPO Year | 1995 | 1996 |
| Metric | DIOD | HAE |
|---|---|---|
| Price | $83.11 | $57.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $82.33 | ★ $85.38 |
| AVG Volume (30 Days) | 422.9K | ★ 587.3K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.53 | 44.54 |
| EPS | 1.43 | ★ 2.46 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | $15.51 | N/A |
| Revenue Next Year | $10.05 | $5.23 |
| P/E Ratio | $57.50 | ★ $23.79 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $33.14 | $47.32 |
| 52 Week High | $82.82 | $87.32 |
| Indicator | DIOD | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 70.95 | 42.16 |
| Support Level | $47.78 | $55.95 |
| Resistance Level | N/A | $66.86 |
| Average True Range (ATR) | 4.16 | 1.81 |
| MACD | 1.46 | 0.44 |
| Stochastic Oscillator | 89.07 | 44.58 |
Diodes Inc is a manufacturer and supplier of high-quality application-specific products within the broad discrete, logic, analog, and mixed-signal semiconductor markets. It serves the customer electronics, computing, communications, industrial, and automotive markets. The Company's products include diodes; rectifiers; transistors; MOSFETs; GPP bridges; GPP rectifiers; protection devices; function-specific arrays; single gate logic; amplifiers and comparators; Hall-effect and temperature sensors; and power management devices, including LED drivers, AC-DC converters and controllers, DC-DC switching and linear voltage regulators, voltage references along with special-function devices, such as USB power switches, load switches, voltage supervisors, and motor controllers.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.